Indoor linden eczemaL23.8

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Allergic contact dermatitis due to contact with the leaves of the large-leaved linden (Sparmannia africana).

General therapyThis section has been translated automatically.

Epicutaneous testing, avoidance of the triggering agent.

External therapyThis section has been translated automatically.

Initially glucocorticoid-containing external preparations 0.25% prednicarbate (e.g. Dermatop ointment), 0.1% methylprednisolone (e.g. Advantan) later bland-nursing therapy. S.a. allergic contact eczema.

Internal therapyThis section has been translated automatically.

Oral antihistamines: Levocetirizine (e.g. Xusal) 1 tbl/day or Desloratadine (e.g. Aerius) 1 tbl/day. Possible sedative antihistamines: clemastine (e.g. Tavegil) 2 times/day 1 tbl. p.o. or dimetinden (e.g. Fenistil) 2 times/day 1 tbl. p.o.

Authors

Last updated on: 29.10.2020